34 research outputs found
The Uniqueness of Spectator Sport from a Strategic Management Perspective: The Case for Spectatoritis
This conceptual paper uses a strategic management approach to assess the unique structure of the business of spectator sport. We argue there is a lack of business competition because franchises are simultaneous co-producers, collaborators, buyers, and suppliers. Consequently, mainstream strategic management frameworks that rely on competitive environments are ill-equipped to evaluate the nuances of spectator sport. In response to these observations, we develop multiple new and modified frameworks, including a spectator sport supply chain that inextricably links the participatory and spectator sport segments. Through this hierarchy of training, participants evolve from paid customers to inputs to production. Spectator sport and its supply chain are then positioned in the center of a revised industry model to develop a theory of spectatoritis, which is a rational explanation for why spectator sport is not only a natural focus for research, but also furnishes considerable promise for the development of unique sport management theory
Examining the Role of Relative Age on Leadership Behaviours among Female Ice Hockey Players: An Exploratory Investigation
The aim of this study was to examine the influence of relative age on self-reported leadership behaviors among competitive female ice hockey players. Secondary purposes included examining whether a relative age effect (RAE) was present within the sample and if leadership behaviors differed according to leader status (i.e., formal versus informal leaders). Canadian female ice hockey players (ages 15-18 years) completed an online survey that contained the Leadership Scale for Sport along with additional demographic questions. Players were segmented into birth quartiles based upon Hockey Canada’s selection date and classified by leadership status. The MANOVA suggested that the frequency of leadership behaviors displayed by these athletes did not differ across birth quartiles. Furthermore, although there was a RAE trend within this sample of competitive female ice hockey players, the differences relative to population distributions were not statistically significant. Finally, formal leaders (i.e., captains/alternate captains) reported higher levels of social support, positive feedback, democratic behavior, and training and instruction than informal leaders. It appears that relative age is not a discriminating factor with respect to leadership behaviors. Competitive female ice hockey may be an avenue for all players, regardless of their date of birth, to develop and demonstrate leadership
Rebranding: The Effect of Team Name Changes on Club Revenue
Research question: The purpose of this study is to explore the financial effect of four types of team name changes, three of which have not been previously studied. We do so in the context of development leagues where rebranding occurs with considerable frequency, thus affecting a great number of sport managers.
Research methods: The effect of rebranding on club revenue was derived by combining the results of two analyses. The first used an economic demand equation to examine the attendance variations of 475 Minor League Baseball teams in 244 cities in the United States and Canada between 1980 and 2011 that engaged in one (or more) of four different types of name changes. The second examined changes in merchandise sales after a rebranding effort.
Results and Findings: The results indicate that development teams fail to derive financial gains from adopting the names of their major league parent clubs. Instead, teams that abandon unique local names see large attendance decreases suggesting that local names generate greater brand awareness and brand image than their major league counterparts. The largest merchandise gains are generated by teams that adopt new, local names.
Implications: These findings further our understanding of the outcomes of brand management and rebranding efforts by acknowledging that former and future names have varying levels of brand equity that have real effects on consumer purchasing behaviors and subsequent financial gains and losses
An Examination of the Impact of Relative Age Effects and Academic Timing on Intercollegiate Athletics Participation in Women’s Softball
This investigation makes three noteworthy contributions to literature on the Relative Age Effect (RAE); 1) it adds to the small number of studies in women’s sports, 2) it is one of very few papers to examine the RAE in intercollegiate athletics, and 3) it (re-)introduces “academic timing” to the discussion of RAEs in this context. The 50 top-ranked NCAA Division I women’s softball teams at the conclusion of the 2011 season served as the focus for this investigation. Student-athletes were grouped into quartiles according to their birth date and identified as “on-time” or “academically delayed” based on their birth year and eligibility status. On-time student-athletes were over four times more likely to be born in quartile one than in quartile four, demonstrating a traditional RAE. This pattern was reversed for those who were academically delayed, with quartile four birth dates constituting more than half of the entire sample
Rebranding : the effect of team name changes on club revenue
RESEARCH QUESTION : The purpose of this study is to explore the financial effect of four types of team name changes, three of which have not been previously studied. We do so in the context of development leagues where rebranding occurs with considerable frequency, thus affecting a great number of sport managers.
RESEARCH METHODS : The effect of rebranding on club revenue was derived by combining the results of two analyses. The first used an economic demand equation to examine the attendance variations of 475 Minor League Baseball teams in 244 cities in the United States and Canada between 1980 and 2011 that engaged in one (or more) of four different types of name changes. The second examined changes in merchandise sales after a rebranding effort.
RESULTS AND FINDINGS : The results indicate that development teams fail to derive financial gains from adopting the names of their major league parent clubs. Instead, teams that abandon unique local names see large attendance decreases suggesting that local names generate greater brand awareness and brand image than their major league counterparts. The largest merchandise gains are generated by teams that adopt new, local names. IMPLICATIONS : These findings further our understanding of the outcomes of brand management and rebranding efforts by acknowledging that former and future names have varying levels of brand equity that have real effects on consumer purchasing behaviors and subsequent financial gains and losses.http://www.tandfonline.com/loi/resm202018-02-28hb2016Gordon Institute of Business Science (GIBS
Multiwavelength Observations of A0620-00 in Quiescence
[Abridged.] We present multiwavelength observations of the black hole binary
system, A0620-00. Using the Cosmic Origins Spectrograph on the Hubble Space
Telescope, we have obtained the first FUV spectrum of A0620-00. The observed
spectrum is flat in the FUV and very faint (with continuum fluxes \simeq 1e -
17 ergs/cm^2/s/A). We compiled the dereddened, broadband spectral energy
distribution of A0620-00 and compared it to previous SEDs as well as
theoretical models. The SEDs show that the source varies at all wavelengths for
which we have multiple samples. Contrary to previous observations, the
optical-UV spectrum does not continue to drop to shorter wavelengths, but
instead shows a recovery and an increasingly blue spectrum in the FUV. We
created an optical-UV spectrum of A0620-00 with the donor star contribution
removed. The non-stellar spectrum peaks at \simeq3000 {\deg}A. The peak can be
fit with a T=10,000 K blackbody with a small emitting area, probably
originating in the hot spot where the accretion stream impacts the outer disk.
However, one or more components in addition to the blackbody are needed to fit
the FUV upturn and the red optical fluxes in the optical-UV spectrum. By
comparing the mass accretion rate determined from the hot spot luminosity to
the mean accretion rate inferred from the outburst history, we find that the
latter is an order of magnitude smaller than the former, indicating that
\sim90% of the accreted mass must be lost from the system if the predictions of
the disk instability model and the estimated interoutburst interval are
correct. The mass accretion rate at the hot spot is 10^5 the accretion rate at
the black hole inferred from the X-ray luminosity. To reconcile these requires
that outflows carry away virtually all of the accreted mass, a very low rate of
mass transfer from the outer cold disk into the inner hot region, and/or
radiatively inefficient accretion.Comment: ApJ, accepte
The James Webb Space Telescope Mission
Twenty-six years ago a small committee report, building on earlier studies,
expounded a compelling and poetic vision for the future of astronomy, calling
for an infrared-optimized space telescope with an aperture of at least .
With the support of their governments in the US, Europe, and Canada, 20,000
people realized that vision as the James Webb Space Telescope. A
generation of astronomers will celebrate their accomplishments for the life of
the mission, potentially as long as 20 years, and beyond. This report and the
scientific discoveries that follow are extended thank-you notes to the 20,000
team members. The telescope is working perfectly, with much better image
quality than expected. In this and accompanying papers, we give a brief
history, describe the observatory, outline its objectives and current observing
program, and discuss the inventions and people who made it possible. We cite
detailed reports on the design and the measured performance on orbit.Comment: Accepted by PASP for the special issue on The James Webb Space
Telescope Overview, 29 pages, 4 figure
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
Background
Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear.
Methods
RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047.
Findings
Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths.
Interpretation
Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
Background
Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain.
Methods
RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and
ClinicalTrials.gov
,
NCT00541047
.
Findings
Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths.
Interpretation
Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy.
Funding
Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society